Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Kedudukan dalam Saham #3341
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$6.27
Modal Pasaran
$5.62B
Perubahan (1 hari)
-0.46%
Perubahan (1 tahun)
26.35%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategori

Nisbah P/S bagi Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH